Live feed
Filing
SC 13G/A
SC 13G/A0001999371-24-002149·Affinity Asset Advisors, LLC
Schedule 13G ownership disclosure
Spyre Therapeutics Inc
Security class unavailable · CUSIP: 00773J202
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 653,409
- Percent of class
- 1.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-24-002149
- Form type
- SC 13G/A
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- Feb 13, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership